Thalidamide and cancer

Thalidomide, an oral agent with antiangiogenic and immunomodulatory properties, is being investigated extensively in the management of advanced cancer Thalidomide (Thalidomid ) is a biological therapy that may be used to treat myeloma

22 Aug 2014 It39s being studied for use against some other cancers. Thalidomide is known to be an immunomodulating agent, which means that it affects

20 Oct 2014 Despite its dark past, thalidomide is being re-explored as part of a new trend in cancer research: investigating old non-cancer drugs as Thalidomide in cancer. Singhal S(1), Mehta J. Author information: (1)Division of HematologyOncology, Northwestern University Medical School and The Robert Who Should Not Take Thalidomide 15. How Is Thalidomide Given 16. Can Thalidomide Be Taken. With Other Cancer Treatments 17. Will Insurance Cover

Thalidomide in cancer medicine

Thalidomide is an immunomodulatory drug and the prototype of the thalidomide class of drugs. It was first marketed in 1957 in Now, decades later, thalidomide is being used to treat a skin condition and cancer. It39s being investigated as a treatment for many other disorders

3 May 2013 Thalidomide is pronounced as tha-lid-oh-mide. It is a type of cancer growth blocker. Researchers are still looking at how thalidomide works 5 Oct 2006 This page contains brief information about thalidomide and a collection of links to National Cancer Institute at the National Institutes of Health